针对EpCAM核医学探针的新兴应用:当前的研究和未来的前景
Zhidie Huang1, Yiwen Li1, Min Li1
1Inner Mongolia Medical University, Hohhot, People's Republic of China.
International journal of nanomedicine
|September 10, 2025
概括
核医学分子成像使用放射性核化物探针进行非侵入性瘤诊断和治疗. 本综述涵盖了上皮细胞粘附分子 (EpCAM) 向的探针,包括DARPins,抗体和体,以改善癌症检测.
科学领域:
- 核医学是一种核医学.
- 分子成像学分子成像学
- 在瘤学瘤学.
背景情况:
- 核医学中的分子成像通过可视化功能局部化提供非侵入性瘤诊断和治疗.
- 放射性核素分子探针的开发对于识别特定瘤点至关重要.
- 表皮细胞粘附分子 (EpCAM) 是有前途的瘤标,因为它们的流行率和瘤进展中的作用.
研究的目的:
- 提供对EpCAM准放射性核素探针近期进展的全面审查.
- 专注于主要配体,如DARPins,抗体和体.
- 评估这些探测器的好处,挑战和未来方向.
主要方法:
- 关于针对EpCAM的放射性核素探针的最新科学文献的综述.
- 专注于DARPins (设计Ankyrin重复蛋白),抗体,和aptamers作为向配体.
- 评估探头性能,包括特异性,有效性和局限性.
主要成果:
- EpCAM是一种广泛存在的抗原标记物,是瘤发生和进展不可或缺的组成部分.
- 达尔宾,抗体和胺体显示出对EpCAM向的放射性核素探针的配体的潜力.
- 每种连接体类型在探针开发和应用方面都有独特的好处和挑战.
结论:
- 针对EpCAM的放射性核化物探针代表了癌症诊断和治疗分子成像技术的重大进步.
- 需要进一步的研究来优化探头设计,并克服临床翻译的现有挑战.
- 审查的配体为开发有效的EpCAM向剂提供了多种策略.
相关概念视频
Positron Emission Tomography
7.0K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
7.0K
Imaging Studies II: Positron Emission Tomography and Scintigraphy
508
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
508
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K

![Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F68356.jpg&w=3840&q=50)
